Source: Annual Congress 2007 - Smoking and the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Menshutina, O. Tumanova, V. Trofimov, N. Shaporova, N. Petrishchev (Saint-Petersburg, Russian Federation). Some pathogenetic mechanisms of inflammatory processes in smoking patients with COPD. Eur Respir J 2007; 30: Suppl. 51, 1061

Member's Comments

No comment yet.

Related content which might interest you: To the molecular genetic mechanisms of the COPD pathogenesis Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 The effect of smoking on the activity of inflammatory markers in patients with COPD Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Differential regulation of inflammatory pathways in alveolar macrophages from COPD patients and smoking controls Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007 Similarities and differences in inflammatory mechanisms of asthma and COPD Source: Breathe 2011; 7: 229-238 Year: 2011 Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016 The role of pathophysiological aspects and inflammatory markers in phenotyping COPD Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010 The potential mechanism of Th17/Treg imbalance in the microenvironments of chronic inflammation and allergic asthma Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Possible role of airway mechanical stress in the genesis of COPD in smokers. The obesity model Source: Eur Respir J 2005; 26: Suppl. 49, 360s Year: 2005 Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms? Source: Annual Congress 2005 - Lung structure: current concepts Year: 2005 Possible mechanisms of protection of lung tissue in smokers without COPD Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD Year: 2007 Possible mechanisms underlying the development of cachexia in COPD Source: Eur Respir J 2008; 31: 492-501 Year: 2008 Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011 COPD disease progression and airway inflammation: uncoupled by smoking cessation Source: Eur Respir J 2005; 26: 764-766 Year: 2005 Some aspects of COPD ethiopathogenesis Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology Source: ERS Satellites 2021 Year: 2021 The tobacco smoking influence on parodontic inflammation in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 167s Year: 2007